Safety and efficacy of enterprise stenting for symptomatic atherosclerotic severe posterior circulation stenosis

PURPOSE: To investigate the safety and efficacy of Enterprise stent angioplasty and risk factors for the prognoses in treating symptomatic severe posterior circulation atherosclerotic stenosis (SSPCAS). MATERIALS AND METHODS: Patients with SSPCAS who were treated with the Enterprise stent angioplast...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhi-Long, Li, Tian-Xiao, Zhu, Liang-Fu, Wu, Li-Heng, Guan, Min, Ma, Zhen-Kai, Liu, Yang-Hui, Qin, Jin, Gao, Bu-Lang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433544/
https://www.ncbi.nlm.nih.gov/pubmed/37592323
http://dx.doi.org/10.1186/s40001-023-01260-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433544/
https://www.ncbi.nlm.nih.gov/pubmed/37592323
http://dx.doi.org/10.1186/s40001-023-01260-x

Ejemplares similares